| Dr Mark H Keeler, PHD | |
|
687 Highland Ave, Needham, MA 02494-2232 | |
| (617) 254-3800 | |
| (617) 779-1482 |
| Full Name | Dr Mark H Keeler |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 31 Years |
| Location | 687 Highland Ave, Needham, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063579183 | NPI | - | NPPES |
| W06000 | Other | MA | BLUE CROSS-BLUE SHIELD |
| 110022270A | Medicaid | MA | |
| 0500054 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 7092 (Massachusetts) | Secondary |
| 103G00000X | Clinical Neuropsychologist | 7092 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boston Neuropsychological Services Llc | 2668538794 | 10 |
News Archive
Eli Lilly and Company have announced key findings from analyses of prior study data that enhances understanding of vision loss due to diabetic retinopathy, a diabetic microvascular complication that affects an estimated 50 million people worldwide.
Some of the state's features that advocates say helped consumers make their insurance-purchasing decisions were not included in the the federal health law.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Just like in earlier attempts to overhaul the American health system, opponents have turned to scare tactics, a strategy with a success rate in the history of blocking health reform, NPR reports. "It's really a case of deja vu," political scientist Jonathan Oberlander tells NPR. "You hear in today's debate echoes of the past that extend all the way to the early part of the 20th century."
› Verified 5 days ago
| Entity Name | Boston Neuropsychological Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407048432 PECOS PAC ID: 2668538794 Enrollment ID: O20090304000750 |
News Archive
Eli Lilly and Company have announced key findings from analyses of prior study data that enhances understanding of vision loss due to diabetic retinopathy, a diabetic microvascular complication that affects an estimated 50 million people worldwide.
Some of the state's features that advocates say helped consumers make their insurance-purchasing decisions were not included in the the federal health law.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Just like in earlier attempts to overhaul the American health system, opponents have turned to scare tactics, a strategy with a success rate in the history of blocking health reform, NPR reports. "It's really a case of deja vu," political scientist Jonathan Oberlander tells NPR. "You hear in today's debate echoes of the past that extend all the way to the early part of the 20th century."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark H Keeler, PHD 259 Rock St Apt A10, Norwood, MA 02062-4977 Ph: (781) 769-9689 | Dr Mark H Keeler, PHD 687 Highland Ave, Needham, MA 02494-2232 Ph: (617) 254-3800 |
News Archive
Eli Lilly and Company have announced key findings from analyses of prior study data that enhances understanding of vision loss due to diabetic retinopathy, a diabetic microvascular complication that affects an estimated 50 million people worldwide.
Some of the state's features that advocates say helped consumers make their insurance-purchasing decisions were not included in the the federal health law.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Just like in earlier attempts to overhaul the American health system, opponents have turned to scare tactics, a strategy with a success rate in the history of blocking health reform, NPR reports. "It's really a case of deja vu," political scientist Jonathan Oberlander tells NPR. "You hear in today's debate echoes of the past that extend all the way to the early part of the 20th century."
› Verified 5 days ago